0001209191-15-074184.txt : 20151005
0001209191-15-074184.hdr.sgml : 20151005
20151005201512
ACCESSION NUMBER: 0001209191-15-074184
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151001
FILED AS OF DATE: 20151005
DATE AS OF CHANGE: 20151005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arbuckle Stuart A
CENTRAL INDEX KEY: 0001557290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151144875
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-10-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001557290
Arbuckle Stuart A
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP\Chief Commercial Officer
Common Stock
2015-10-01
4
S
0
700
102.30
D
126815
D
Common Stock
2015-10-01
4
S
0
900
103.28
D
125915
D
Common Stock
2015-10-01
4
S
0
5159
104.45
D
120756
D
Common Stock
2015-10-01
4
S
0
5058
105.41
D
115698
D
Common Stock
2015-10-01
4
S
0
600
106.07
D
115098
D
Common Stock
140
I
401(k)
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $102.30 (range $101.68 to $102.66).
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $103.28 (range $102.71 to $103.60).
Open market sales reported on this line occurred at a weighted average price of $104.45 (range $103.89 to $104.88).
Open market sales reported on this line occurred at a weighted average price of $105.41 (range $104.91 to $105.90).
Open market sales reported on this line occurred at a weighted average price of $106.07 (range $105.99 to $106.12).
Omar White, Attorney-In-Fact
2015-10-05